foxo4-dri senolytic animal model 2023 2024

foxo4-dri senolytic animal model 2023 2024 Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis 2022 Lupus Highlight - Therapeutic

Name: foxo4-dri senolytic animal model 2023 2024 Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis 2022 Lupus Highlight - Therapeutic
Brand: centoria.fr
SKU: 6847316844
Price: 28.63 USD
Availability: InStock
Rating: 4.3024 (5 reviews)

2022 Lupus Highlight Therapeutic Targeting of Senescent Cells in Lupus, Lupus Research Program, Congressionally Directed Medical Research Programs The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect ES2 rapidly destroys TP53 FOXO4 foci leading to TP53 mediated Download Scientific Diagram

SKU: 6847316844 · From centoria.fr

4.3

USD28.63 USD71.63

Pay in 4 interest-free payments of $7.16 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Several voting members work for or advise companies that stand to benefit commercially from peptide sales a conflict flagged by researchers and consumer-safety advocates

What are the primary therapeutic applications being investigated for these peptides

The hepatocyte growth factor (HGF)/c-MET pathway is upregulated in PC and mediates the interaction between cancer cells and stromal pancreatic stellate cells (PSCs)